Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down

MT Newswires Live

07/16

Harmony Biosciences (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.

Analysts polled by FactSet expect $249.5 million.

The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.

Analysts expect $1.01 billion.

In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.

The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.

Harmony will report its Q2 financial results on Aug. 4.

Shares of the company were down more than 1% in premarket activity Thursday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2651442491"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651442491\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651442491?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651442491","market":"us","top_or_hot":-1,"title":"Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.</p><p>Analysts polled by FactSet expect $249.5 million.</p><p>The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.</p><p>Analysts expect $1.01 billion.</p><p>In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.</p><p>The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.</p><p>Harmony will report its Q2 financial results on Aug. 4.</p><p>Shares of the company were down more than 1% in premarket activity Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarmony Biosciences Expects Higher Q2 Wakix Revenue; CFO Glenn Reicin Steps Down\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-16 21:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HRMY\">Harmony Biosciences</a> (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.</p><p>Analysts polled by FactSet expect $249.5 million.</p><p>The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.</p><p>Analysts expect $1.01 billion.</p><p>In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.</p><p>The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.</p><p>Harmony will report its Q2 financial results on Aug. 4.</p><p>Shares of the company were down more than 1% in premarket activity Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2651442491","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651442491","pubTimestamp":1784207207,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Harmony Biosciences  reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.Analysts polled by FactSet expect $249.5 million.The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.Analysts expect $1.01 billion.In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.Harmony will report its Q2 financial results on Aug. 4.Shares of the company were down more than 1% in premarket activity Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HRMY":"Harmony Biosciences Holdings, Inc."},"translate_title":"Harmony Biosciences 预计第二季度 Wakix 收入将增加；首席财务官 Glenn Reicin 辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRMY":1},"content_text":"Harmony Biosciences (HRMY) reported Thursday preliminary Q2 net product revenue for Wakix of around $261 million, up 30% year over year.Analysts polled by FactSet expect $249.5 million.The company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion.Analysts expect $1.01 billion.In addition, the company said Chief Financial Officer Glenn Reicin stepped down to pursue other opportunities, effective immediately.The company said it named Stephen Mollichella, currently the controller, as interim principal financial officer as it conducts its search for a permanent finance chief.Harmony will report its Q2 financial results on Aug. 4.Shares of the company were down more than 1% in premarket activity Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}